SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles

Golden opportunities in the transportation industry in 2026: Focus on the recovery of stocks benefiting from industry dividends and opportunities to counteract internal competition.

Sinolink: Breakthrough in solid-state battery technology & surge in energy storage demand, optimistic about the entire lithium battery industry chain.

Airbnb, Inc. Class A (ABNB.US) 2025Q3 conference call: There is still hope for the market size of the homestay market to double.
Golden opportunities in the transportation industry in 2026: Focus on the recovery of stocks benefiting from industry dividends and opportunities to counteract internal competition.

Sinolink: Breakthrough in solid-state battery technology & surge in energy storage demand, optimistic about the entire lithium battery industry chain.

Airbnb, Inc. Class A (ABNB.US) 2025Q3 conference call: There is still hope for the market size of the homestay market to double.

RECOMMEND

Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025

Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025

Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025


